Kuo Qu
Changchun, 130033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Frequency-selective thymic programming by early-life cold stress requires interferon regulatory factor 5.
Journal: Frontiers in immunology
Published: April 09, 2026
DNMT1 knockdown mitigates sepsis-induced myocardial dysfunction by preventing TFAM-mediated mitochondrial DNA cytosolic escape and subsequent cGAS-STING to regulate macrophage M2 polarization.
Journal: Biochemical pharmacology
Published: October 16, 2025
The association between lipid ratios and type 2 diabetes mellitus in middle-aged and older Chinese adults: A nationwide prospective cohort study (STROBE).
Journal: Medicine
Published: October 12, 2025
Enhancement of antitumor immunity by CTLA-4 antisense oligonucleotides with CpG motif in mice.
Journal: International immunopharmacology
Published: July 08, 2025
Pre-activation timing determines influenza severity and viral pathogenicity via STING Inhibition.
Journal: Scientific reports
Published: June 17, 2025
A decoy oligodeoxynucleotide favors the differentiation of CpG ODN-induced B cells into IL-10-producing Breg-like cells over plasma cells by restoring IRF4/IRF8 imbalance.
Journal: Cellular and molecular life sciences : CMLS
Published: April 18, 2025
Plasma Exosomal circRNAs as Potential Biomarkers for Patients with Septic Shock-Induced Acute Kidney Injury.
Journal: Biotechnology and applied biochemistry
Published: January 02, 2025
Trailblazing in adjuvant research: succinate's uncharted territory with neutrophils.
Journal: American journal of physiology. Cell physiology
Published: May 06, 2024
The trogocytosis of neutrophils on initial transplanted tumor in mice.
Journal: iScience
Published: July 29, 2023
Massively recruited sTLR9+ neutrophils in rapidly formed nodules at the site of tumor cell inoculation and their contribution to a pro-tumor microenvironment.
Journal: Cancer immunology, immunotherapy : CII
Published: December 22, 2022
Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor.
Journal: Cancer immunology, immunotherapy : CII
Published: January 26, 2022
Last Updated: 09/26/2026